Smartphone Technology to Alleviate Malignant Pain (STAMP)

Study summary

The purpose of the study is to develop the STAMP app (Smartphone Technology to Alleviate Malignant Pain). This app will be used by patients with advanced cancer to track symptoms and receive tailored symptom management advice. This is a single arm pilot feasibility study of the application among patients with advanced cancer and chronic pain who are using opioids in the home setting. Patients will be asked to use the application for a four week period. Clinicians responsible for the patients' pain management will be asked to review alerts from the STAMP system and respond accordingly. The primary outcomes of the study relate to feasibility and acceptability.

Ask AI to explain this study

Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedIntervention Participants

The study team can explain what participation involves.

Who it may be forCancer · Pain Management

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 5, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Dana-Farber Cancer Institute

Study sponsor

Study overview

What this study is about

Purpose: Health Services Research
Study type: Interventional
Phase: Not applicable
Sponsor: Dana-Farber Cancer Institute
Interventions being studied: Behavioral: Intervention Participants

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patient Inclusion Criteria:
Patient is cared for within participating clinic (PC)
Age ≥21
Diagnosed with locally advanced, metastatic solid tumor, or multiple myeloma being managed with palliative intent
Chronic pain related to cancer or cancer treatment, persisting or at least two weeks
Average pain rating of ≥4/10 currently, or at least one day within the past week
Active prescription for short and/or long acting opioids
Takes at least 1 opioid medication on most days
Own a compatible smartphone:
iPhone, have updated or willing to update it to the past 3 iOS version releases
Android flagship devices with more than 5% market share, last 2 android version releases Clinician Inclusion Criteria:
Physicians and mid-level providers practicing in participating clinics and caring for a patient on the study
Nurse Navigators working within participating clinics

Reasons someone may not be able to joinExclusion criteria

Patient

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Dana Farber Cancer InstituteBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 5, 2023. Always confirm current availability with the study team.

View original record ↗